Микробная популяция респираторной системы у детей с муковисцидозом
Аннотация
Муковисцидоз (МВ) - мультисистемное заболевание, которое приводит к высокой забо-леваемости и смертности, имеет аутосомно-рецессивное наследование и в первую очередь поражает дыхательную систему. В статье представлена информация об исследовании микробной популяции дыхательных путей у детей с муковисцидозом при тестировании потом. В исследовании, проведенном в Научно-Исследовательский Институт Педиатрии имени К.Я.Фараджевой, потовые пробы были выполнены у 128 пациентов. В результате исследования 34 (27,6%) пациента были признаны подозрительными на МВ, а 14 (11,4%) пациента были признаны значимыми. Таким образом, при дифференциальной диагностике рецидивирующих заболеваний нижних и верхних дыхательных путей считается целесо-образным исследование муковисцидоза с помощью потовой пробы.
Библиографические ссылки
Lynch SV, Bruce KD. The cystic fibrosis airway microbiome. Cold Spring Harbor perspectives in medicine. 2013;3(3):a009738.
Horré R, Symoens F, Delhaes L, Bouchara J-P. Fungal respiratory infections in cystic fibrosis: a growing problem. Sabouraudia. 2010;48(Supplement_1):S1-S3.
Hampton TH, Green DM, Cutting GR, Morrison HG, Sogin ML, Gifford AH, et al. The microbiome in pediatric cystic fibrosis patients: the role of shared environment suggests a window of intervention. Microbiome. 2014;2(1):1-5.
Blanchard AC, Waters VJ, editors. Microbiology of cystic fibrosis airway disease. Seminars in respiratory and critical care medicine; 2019: Thieme Medical Publishers.
Ahlgren HG, Benedetti A, Landry JS, Bernier J, Matouk E, Radzioch D, et al. Clinical outcomes associated with Staphylococcus aureus and Pseudomonas aeruginosa airway infections in adult cystic fibrosis patients. BMC pulmonary medicine. 2015;15(1):1-6.
Malhotra, S., Hayes Jr, D., & Wozniak, D. J.. Mucoid Pseudomonas aeruginosa and regional inflammation in the cystic fibrosis lung. Journal of Cystic Fibrosis, 2019, 18(6), 796-803.
Harrison F. Microbial ecology of the cystic fibrosis lung. Microbiology. 2007;153(4):917-23.
Fodor AA, Klem ER, Gilpin DF, Elborn JS, Boucher RC, Tunney MM, et al. The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations. 2012.
Filkins LM, O’Toole GA. Cystic fibrosis lung infections: polymicrobial, complex, and hard to treat. PLoS pathogens. 2015;11(12):e1005258.
Doğru D. Kistik fibroziste tanı. Katkı Pediatri Dergisi 2002;23:209-17
Cinel G. Ter testi. Çocuk göğüs hastalıklarında tanı yöntemleri İstanbul: Probiz Ltd. 2016:118-24.
Rafeeq, Misbahuddin M.; MURAD, Hussam Aly Sayed. Cystic fibrosis: current therapeutic targets and future approaches. Journal of translational medicine, 2017, 15.1: 1-9.
Spencer H, Jaffe A. Newer therapies for cystic fibrosis. Current Paediatrics 2003: 13; 259-263.
Barben, Jürg, et al. The expansion and performance of national newborn screening programmes for cystic fibrosis in Europe. Journal of Cystic Fibrosis, 2017, 16.2: 207-213.
Semerci N. Sık alt ve üst solunum yolu enfeksiyonu geçiren olgularda ter testi ile kistik fibrozis taranması: Adnan Menderes Üniversitesi; 2005.
Ratjen F, Walter H, Haug M, Meisner C, Grasemann H, Döring G. Diagnostic value of serum antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis patients. Pediatric pulmonology. 2007;42(3):249-55.
Cesur Y, Doğan M, Arıyuca S, Peker E, Okur M, Akbayram S, et al. Hastaneye başvuran malnutrisyonu ve/veya tekrarlayan akciğer enfeksiyonu olan çocuklarda kistik fibrozis sıklığı araştırılması. Selçuk Ünv Tıp Derg. 2010;26:138-41.
Ramsey, Mitchell L., et al. Cystic fibrosis transmembrane conductance regulator modulators and the exocrine pancreas: A scoping review. Journal of Cystic Fibrosis, 2022.
Castellani C, Cuppens H, Macek Jr M, Cassiman J, Kerem E, Durie P, et al. Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice. Journal of cystic fibrosis. 2008;7(3):179-96.
Al-Haggar, Mohammad, et al. Screening for the Most Common Mutations of CFTR Gene among Egyptian Children with Difficult-to-Treat Asthma. Journal of Pediatric Genetics, 2020, 9.03: 164-170.
Kaya A, Derman U, Yaramış A ve ark. Güneydoğu Anadolu bölgesindeki kistik fibrozisli 23 hastanın klinik ve laboratuar özellikleri. Çocuk Sağlığı ve Hastalıkları Dergisi 2010; 43: 345-51.
Esther Jr CR, Esserman DA, Gilligan P, Kerr A, Noone PG. Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis. Journal of Cystic Fibrosis. 2010;9(2):117-23.
Fernández-Barat L, Ciofu O, Kragh KN, Pressler T, Johansen U, Motos A, et al. Phenotypic shift in Pseudomonas aeruginosa populations from cystic fibrosis lungs after 2-week antipseudomonal treatment. Journal of Cystic Fibrosis. 2017;16(2):222-9.
Smyth AR, Bell SC, Bojcin S, Bryon M, Duff A, Flume P, et al. European cystic fibrosis society standards of care: best practice guidelines. Journal of cystic fibrosis. 2014;13:S23-S42.
Ключевые слова
потовая проба
микробная популяция респираторной системы kistik fibroz
tər testi
tənəffüs yolu mikrob populyasiyası сystic fibrosis
sweat test
respiratory system microbial population